Cargando…
The Microbiome in Systemic Sclerosis: Pathophysiology and Therapeutic Potential
Systemic sclerosis (SSc), also known as scleroderma, is an autoimmune disease with unknown etiology characterized by multi-organ fibrosis. Despite substantial investigation on SSc-related cellular and molecular mechanisms, effective therapies are still lacking. The skin, lungs, and gut are the most...
Autores principales: | Kim, Suhee, Park, Hee Jin, Lee, Sang-Il |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853331/ https://www.ncbi.nlm.nih.gov/pubmed/36555792 http://dx.doi.org/10.3390/ijms232416154 |
Ejemplares similares
-
Systemic Sclerosis: From Pathophysiology to Novel Therapeutic Approaches
por: Benfaremo, Devis, et al.
Publicado: (2022) -
Adipose-derived stem cells: Pathophysiologic implications vs therapeutic potential in systemic sclerosis
por: Rosa, Irene, et al.
Publicado: (2021) -
The Gut Microbiome in Multiple Sclerosis: A Potential Therapeutic Avenue
por: Kirby, Trevor O., et al.
Publicado: (2018) -
Gut microbiome in systemic sclerosis: a potential therapeutic target
por: Polkowska-Pruszyńska, Beata, et al.
Publicado: (2020) -
‘The Microbiome and the Pathophysiology of Asthma’
por: Sullivan, Ashley, et al.
Publicado: (2016)